Home  >  News
  Researchers confirm new genetic mutation link to amyotrophic lateral sclerosis,   March 23, 2018
  Edwards completes patient enrollment in PARTNER 3 trial of SAPIEN 3 valve to treat severe aortic stenosis,   March 23, 2018
  AstraZeneca receives European marketing approval for Lokelma to treat adults with hyperkalaemia,   March 23, 2018
  US FDA approves Novartis' Tasigna to treat children with rare form of leukemia,   March 23, 2018
  NEI researchers find immune cells in retina can spontaneously regenerate,   March 23, 2018
  Assocham-Velocity MR report highlights India’s medical waste growing at 7% annually,   March 23, 2018
  Bio-Techne expands ACD-branded RNAscope ISH technology to facilitate drug discovery and development,   March 23, 2018
  Titan Pharma licenses European commercialization rights of Probuphine to Molteni,   March 23, 2018
  Regeneron, Alnylam Pharma collaborate to discover new treatments for NASH,   March 23, 2018
  AbbVie, IMF partner to study role of genetic mutation in outcomes of patients with MM,   March 23, 2018
  Chinese FDA accepts Chugai Pharma's NDA for eldecalcitol to treat osteoporosis,   March 23, 2018
  Invicro introduces AmyloidIQ to advance clinical imaging trials in Alzheimer’s disease,   March 22, 2018
  Columbia Asia receives additional equity investment of USD 210 million,   March 22, 2018
  Researchers discover human antibody that prevents malaria in mice,   March 22, 2018
  Health ministry launches national campaign to warn against dangers of second-hand smoke exposure,   March 22, 2018
  US FDA approves Seattle Genetics' Adcetris in combo with chemotherapy in adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma,   March 22, 2018
  DPSRU, IASTAM organize international conference on Ayush and natural products,   March 22, 2018
  Tata Chemicals launches India’s first branded pharmaceutical grade sodium bicarbonate,   March 22, 2018
  Trice Medical’s mi-eye 2 receives CE Mark & Health Canada approval,   March 22, 2018
  Sun Pharma receives US FDA approval for Ilumya to treat moderate-to-severe plaque psoriasis,   March 22, 2018

cphikorea_150x60_saffron media
Copyright © 2016 Saffron Media Pvt. Ltd |